Clinical drug therapy : (Record no. 10121)

MARC details
000 -LEADER
fixed length control field 04845cam a22003014a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20231011134818.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 080721s2009 paua b 001 0 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780781721219
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0781721210
040 ## - CATALOGING SOURCE
Original cataloging agency BUL
Transcribing agency BUL
Modifying agency BUL
Language of cataloging eng
Description conventions rda
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 55 A161c 2001
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Abrams, Anne Collins.
245 10 - TITLE STATEMENT
Title Clinical drug therapy :
Remainder of title rationales for nursing practice /
Statement of responsibility, etc. Anne Collins Abrams ; consultant, Tracey L. Goldsmith.
250 ## - EDITION STATEMENT
Edition statement 6th edition
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Philadelphia :
Name of publisher, distributor, etc. Lippincott Williams & Wilkins,
Date of publication, distribution, etc. c2001.
300 ## - PHYSICAL DESCRIPTION
Extent xxi, 1069 p. :
Other physical details col. ill. ;
Dimensions 28 cm.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Contents<br/><br/>Section 1: FOUNDATIONS OF DRUG THERAPY<br/><br/>Chapter. 1: Introduction to Pharmacology<br/>Chapter. 2: Basic Concepts and Processes<br/>Chapter. 3: Administering Medications<br/>Chapter. 4: Nursing Process in Drug Therapy<br/><br/>Section 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM<br/>Chapter. 5: Physiology of the Central Nervous System<br/>Chapter. 6: Opioid Analgesics and Opioid Antagonists<br/>Chapter. 7: Analgesic?Antipyretic?Anti-Inflammatory and Related Drugs<br/>Chapter. 8: Antianxiety and Sedative-Hypnotic Drugs<br/>Chapter. 9: Antipsychotic Drugs<br/>Chapter. 10: Antidepressants and Mood Stabilizers<br/>Chapter. 11: Antiseizure Drugs<br/>Chapter. 12: Antiparkinson Drugs<br/>Chapter. 13: Skeletal Muscle Relaxants<br/>Chapter. 14: Anesthetics<br/>Chapter 15: Substance Abuse Disorders<br/>Chapter. 16: Central Nervous System Stimulants<br/><br/>Section 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM<br/>Chapter. 17: Physiology of the Autonomic Nervous System<br/>Chapter. 18: Adrenergic Drugs<br/>Chapter. 19: Antiadrenergic Drugs<br/>Chapter. 20: Cholinergic Drugs<br/>Chapter. 21: Anticholinergic Drugs<br/><br/>Section 4: DRUGS AFFECTING THE ENDOCRINE SYSTEM<br/>Chapter. 22: Physiology of the Endocrine System<br/>Chapter. 23: Hypothalamic and Pituitary Hormones<br/>Chapter. 24: Corticosteroids<br/>Chapter. 25: Thyroid and Antithyroid Drugs<br/>Chapter. 26: Hormones That Regulate Calcium and Bone Metabolism<br/>Chapter. 27: Antidiabetic Drugs<br/>Chapter. 28: Estrogens, Progestins, and Hormonal Contraceptives<br/>Chapter. 29: Androgens and Anabolic Steroids<br/><br/>Section. 5. Nutrients, Fluids, and Electrolytes <br/>Chapter. 30. Nutritional Support Products and Drugs for Obesity <br/>Chapter. 31. Vitamins<br/>Chapter. 32. Minerals and Electrolytes <br/><br/>Section. 6. Drugs Used to Treat Infections <br/>Chapter. 33. General Characteristics of Antimicrobial Drugs <br/>Chapter. 34. Beta-Lactam Antibacterials: Penicillins, Cephalosporins, and Others <br/>Chapter. 35. Aminoglycosides and Fluoroquinolones <br/>Chapter. 36. Tetracyclines, Sulfonamides, and Urinary Agents <br/>Chapter. 37. Macrolides and Miscellaneous Antibacterials <br/>Chapter. 38. Drugs for Tuberculosis and Mycobacterium avium Complex (MAC) Disease<br/>Chapter. 39. Antiviral Drugs<br/>Chapter. 40. Antifungal Drugs <br/>Chapter. 41. Antiparasitics <br/><br/>Section. 7. Drugs Affecting Hematopoiesis and the Immune System<br/>Chapter. 42. Physiology of the Hematopoietic and Immune Systems<br/>Chapter. 43. Immunizing Agents <br/>Chapter. 44. Hematopoietic and Immunostimulant Drugs <br/>Chapter. 45. Immunosuppressants<br/><br/>Section. 8. Drugs Affecting the Respiratory System<br/>Chapter. 46. Physiology of the Respiratory System <br/>Chapter. 47. Drugs for Asthma and Other Bronchoconstrictive Disorders<br/>Chapter. 48. Antihistamines and Allergic Disorders <br/>Chapter. 49. Nasal Decongestants, Antitussives, and Cold Remedies<br/><br/>Section. 9. Drugs Affecting the Cardiovascular System <br/>Chapter. 50. Physiology of the Cardiovascular System<br/>Chapter. 51. Drug Therapy of Heart Failure <br/>Chapter. 52. Antidysrhythmic Drugs <br/>Chapter. 53. Antianginal Drugs<br/>Chapter. 54. Drugs Used in Hypotension and Shock<br/>Chapter. 55. Antihypertensive Drugs <br/>Chapter. 56. Diuretics <br/>Chapter. 57. Drugs That Affect Blood Coagulation <br/>Chapter. 58. Drugs for Dyslipidemia <br/><br/>Section. 10. Drugs Affecting the Digestive System<br/>Chapter. 59. Physiology of the Digestive System <br/>Chapter. 60. Drugs Used for Peptic Ulcer and Acid Reflux Disorders<br/>Chapter. 61. Laxatives and Cathartics <br/>Chapter. 62. Antidiarrheals <br/>63. Antiemetics <br/><br/>Section. 11. Drugs Used in Special Conditions<br/>Chapter. 64. Drugs Used in Oncologic Disorders <br/>Chapter. 65. Drugs Used in Ophthalmic Conditions <br/>Chapter. 66. Drugs Used in Dermatologic Conditions<br/>Chapter. 67. Drug Use During Pregnancy and Lactation
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemotherapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nursing.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical Preparations
Form subdivision Nurses' Instruction.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy
Form subdivision Nurses' Instruction.
856 41 - ELECTRONIC LOCATION AND ACCESS
Materials specified Publisher description
Uniform Resource Identifier <a href="http://catdir.loc.gov/catdir/enhancements/fy0712/2003045802-d.html">http://catdir.loc.gov/catdir/enhancements/fy0712/2003045802-d.html</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Book Open Access
Edition 6th edition
Classification part QV 55 A161c 2001
Item part 1
Call number prefix QV 55
Call number suffix A161c 2009
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Source of acquisition Inventory number Total Checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type
    Dewey Decimal Classification     Health Sciences Library Health Sciences Library 02/15/2022 Donation 01266   QV 55 A161c 2001 MBAL22020865 02/15/2022 1 02/15/2022 Book Open Access
    Dewey Decimal Classification     Health Sciences Library Health Sciences Library 02/17/2022 Donation 01112   QV 55 A161c 2001 MBAL22021065 02/17/2022 2 02/17/2022 Book Open Access